MSME (Udyam registered) Ministry of MSME
- Udyam number
- UDYAM-HP-11-0004267
RN Chemicals & Pharmaceutical Private Limited
RN Chemicals & Pharmaceutical Private Limited - pharma in Solan, Himachal Pradesh, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹11.08 Cr
▲ 970% YoY
Net profit · FY 2025
₹5.71 Lakh
Net margin 0.5%
EBITDA · FY 2025
₹8.25 Lakh
EBITDA margin 0.7%
Authorised capital
₹2.5 Cr
Registered with MCA
Paid-up capital
₹1.18 Cr
Issued & subscribed
Open charges
₹5 Cr
Satisfied ₹11 Cr
Company age
8 yrs
Est. 2018
Directors on board
2
As per MCA filings
About RN Chemicals & Pharmaceutical Private Limited
Data last updated:
RN Chemicals & Pharmaceutical Private Limited is a private limited company based in Solan, Himachal Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 17 August 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Himachal Pradesh, under CIN U24100HP2018PTC007121. Its GSTIN is 02AAJCR0909D1ZW (Himachal Pradesh). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹2.5 Cr and a paid-up capital of ₹1.18 Cr. It is led by directors Abhishek Gupta and Viki Vijay Taksali.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Khasra No. 139/ 2 Viilage Jodhapur Barotiwala Baddi, Solan, Himachal Pradesh, India – 174103.
As per the financials filed for FY 2025, the company reported a revenue of ₹11.08 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹5.71 Lakh (net margin 0.5%) and EBITDA of ₹8.25 Lakh (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 56% over three years.
As per MCA filings, the company has open charges of ₹5 Cr and satisfied charges of ₹11 Cr on record.
RN Chemicals & Pharmaceutical Private Limited is registered as an MSME under the Udyam registration framework (Reg. No. UDYAM-HP-11-0004267).
Company details
CIN U24100HP2018PTC007121
Registration Number 007121
Incorporation Date 17 August 2018
ROC Himachal Pradesh
Listing Status Unlisted
Company Status Active
MSME Classification MSME
Udyam Registration UDYAM-HP-11-0004267
Recognitions & Rankings of RN Chemicals & Pharmaceutical
Contact details
RN Chemicals & Pharmaceutical Private Limited's registered office is in Solan, Himachal Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressKhasra No. 139/ 2 Viilage Jodhapur Barotiwala Baddi, Solan, Himachal Pradesh, India – 174103
- IndustryPharma, Drug Formulation & Development
To see the full contact details of RN Chemicals & Pharmaceutical Private Limited, buy the company report.
Comprehensive company report
RN Chemicals & Pharmaceutical Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of RN Chemicals & Pharmaceutical is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of RN Chemicals & Pharmaceutical Private Limited, buy the company report.
Financials of RN Chemicals & Pharmaceutical Private Limited
FY 2025 filings availableRN Chemicals & Pharmaceutical Private Limited reported revenue of ₹11.08 Cr (up 970% YoY) for FY 2025.
Revenue · FY 2025
₹11.08 Cr ▲ 970%
Net profit · FY 2025
₹5.71 Lakh margin 0.5%
EBITDA · FY 2025
₹8.25 Lakh margin 0.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 970%
3 years · compounded
▲ 56%
EBITDA CAGR growth
1 year
▼ 10%
3 years · compounded
▲ 38%
5 years · compounded
▲ 34%
Revenue has grown at a compounded annual rate (CAGR) of 56% over three years, including 970% growth in the latest year. EBITDA fell 10% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹8.25 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.71 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.7% | ||||
| Net Profit Margin | 0.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of RN Chemicals & Pharmaceutical Private Limited, buy the company report.
Board of directors of RN Chemicals & Pharmaceutical Private Limited
RN Chemicals & Pharmaceutical has 2 current directors and 5 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Abhishek Gupta | Director | 05 Sep 2025 | 1 Years 2 Months | Current |
| Viki Vijay Taksali Also directs: Elitus Healthcare Private Limited | Director | 30 Aug 2025 | 1 Years 2 Months | Current |
Peer comparison
RN Chemicals & Pharmaceutical Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| BMW Pharmaco India Private Limited | ₹11.11 Cr (FY 2024) | 0.0% | Jabalpur, Madhya Pradesh, India | |||
| Rowez Life Sciences Private Limited | ₹11.08 Cr (FY 2025) | 3.0% | Kochi, Kerala, India | |||
| RN Chemicals & Pharmaceutical Private Limitedthis company | ₹11.08 Cr (FY 2025) | ₹5.71 Lakh | 0.5% | 970.0% | Solan, Himachal Pradesh, India | |
| Texas Pharmaceuticals Private Limited | ₹11.03 Cr (FY 2025) | 3.0% | Karnal, Haryana, India | |||
| Alenvision Pharma Private Limited | ₹11.01 Cr (FY 2025) | 11.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of RN Chemicals & Pharmaceutical Private Limited, buy the company report.
Auditor
RN Chemicals & Pharmaceutical Private Limited is audited by SINGH BHUPINDER & ASSOCIATES for the financial year 2021.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SINGH BHUPINDER & ASSOCIATES | FY 2021 | 035417N |
Shareholding
The shareholding of RN Chemicals & Pharmaceutical Private Limited is on record for 3 financial years, the latest being FY 2021, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of RN Chemicals & Pharmaceutical Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5 Cr
Satisfied charges
₹11 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 18 Dec 2025 | 101212330 | Others | ₹5 Cr | Open | |
| 27 May 2020 | 100366572 | Others | ₹11 Cr | Satisfied |
To see the full charge records of RN Chemicals & Pharmaceutical Private Limited, buy the company report.
Total charge records: 2 View all charges
Legal cases
No court or tribunal cases involving RN Chemicals & Pharmaceutical Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for RN Chemicals & Pharmaceutical Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
RN Chemicals & Pharmaceutical has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 02AAJCR0909D1ZW | Himachal Pradesh | Active | 16 Oct 2018 |
| 06AAJCR0909D1ZO | Haryana | Active | 30 Jun 2020 |
To see the full GST registrations and return filing status of RN Chemicals & Pharmaceutical Private Limited, buy the company report.
Recent activity
RN Chemicals & Pharmaceutical Private Limited has 8 board changes on record since 2019: 4 appointments and 4 cessations. The latest: Abhishek Gupta was appointed as Director on 05 Sep 2025.
Charges
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 101212330 was registered on 18 Dec 2025.
Charges
A charge registered on 27 May 2020 via Charge ID 100366572 with Others was fully satisfied on 19 Nov 2025.
AGM
Rn Chemicals & Pharmaceutical Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Appointed
Abhishek Gupta was appointed as Director.
Appointed
Viki Vijay Taksali was appointed as Director.
Appointed
Nipur Gupta was appointed as Additional Director.
Filing
Rn Chemicals & Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Himachal Pradesh.
Charges
A charge with Others amounted to Rs. 11.00 Cr with Charge ID 100366572 was registered on 27 May 2020.
Ceased
Ravi Goel ceased to be Director.
Ceased
Rajesh Gupta ceased to be Managing Director.
Ceased
Anil Kumar Gupta ceased to be Director.
Appointed
Neeraj Gupta was appointed as Director.
2 earlier events are in the company report.
Frequently asked questions
RN Chemicals & Pharmaceutical is an active private limited company based in Solan, Himachal Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 17 August 2018 (8+ years old) and is registered under CIN U24100HP2018PTC007121.
RN Chemicals & Pharmaceutical has 2 current directors:
- Abhishek Gupta - Director
- Viki Vijay Taksali - Director
The latest financial statements of RN Chemicals & Pharmaceutical on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of RN Chemicals & Pharmaceutical is 02AAJCR0909D1ZW, registered in Himachal Pradesh. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 06AAJCR0909D1ZO (Haryana).
The CIN (Corporate Identification Number) of RN Chemicals & Pharmaceutical is U24100HP2018PTC007121. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
RN Chemicals & Pharmaceutical was incorporated on 17 August 2018, making it 8+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.
The peers of RN Chemicals & Pharmaceutical by revenue are BMW Pharmaco India Private Limited, Rowez Life Sciences Private Limited, Texas Pharmaceuticals Private Limited, Alenvision Pharma Private Limited, all in the Pharma industry (Formulations), with the same principal business activity (wholesale trading).
Abhishek Gupta was appointed as Director on 05 Sep 2025. Viki Vijay Taksali was appointed as Director on 30 Aug 2025. Nipur Gupta was appointed as Additional Director on 01 Apr 2025. RN Chemicals & Pharmaceutical has 8 board changes on record in total.
Yes, RN Chemicals & Pharmaceutical is registered as an MSME under Udyam registration (number: UDYAM-HP-11-0004267).
The registered office of RN Chemicals & Pharmaceutical is at Khasra No. 139 2 Viilage Jodhapur Barotiwala Baddi, Solan, Himachal Pradesh, India – 174103.
RN Chemicals & Pharmaceutical operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages